The influence of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics of thioridazine and its metabolites: in vivo and in vitro studies
- 31 July 1999
- journal article
- Published by Elsevier in Experimental and Toxicologic Pathology
- Vol. 51 (4-5) , 309-314
- https://doi.org/10.1016/s0940-2993(99)80012-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Selective Serotonin Reuptake Inhibitors and CNS Drug InteractionsClinical Pharmacokinetics, 1997
- Contribution of Lysosomal Trapping to the Total Tissue Uptake of Psychotropic DrugsBasic & Clinical Pharmacology & Toxicology, 1997
- Clinically Relevant Pharmacology of Selective Serotonin Reuptake InhibitorsClinical Pharmacokinetics, 1997
- The effects of selective serotonin reuptake inhibitors and their metabolites on S‐mephenytoin 4'‐hydroxylase activity in human liver microsomes.British Journal of Clinical Pharmacology, 1995
- Inhibition of Alprazolam and Desipramine Hydroxylation In Vitro by Paroxetine and FluvoxamineJournal of Clinical Psychopharmacology, 1995
- Metabolism of thioridazine by microsomal monooxygenases: relative roles of P450 and flavin-containing monooxygenaseXenobiotica, 1995
- Fluvoxamine is a potent inhibitor of cytochrome P4501A2Biochemical Pharmacology, 1993
- The effect of selective serotonin re‐uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.British Journal of Clinical Pharmacology, 1992
- Anorectic activity of fluoxetine and norfluoxetine in mice, rats and guinea-pigsJournal of Pharmacy and Pharmacology, 1992
- Clinical implications of slow sulphoxidation of thioridazine in a poor metabolizer of the debrisoquine typeEuropean Journal of Clinical Pharmacology, 1990